AeroRx Therapeu&cs
Latest round
- Series A
Last raised
- Sep 2025
Total raised
- $10M
Investors
- 3
About AeroRx Therapeu&cs
AeroRx Therapeutics, Inc.AeroRx Therapeutics, Inc. specializes in developing innovative nebulized therapies. Founded in 2023 and headquartered in La Jolla, US, the company has undergone strategic developments to enhance its product offerings.AeroRx Therapeutics focuses on developing advanced nebulized combination therapies targeting patients with chronic obstructive pulmonary disease (COPD). The company offers AERO-007, a fixed-dose combination of long-acting beta2 agonists (LABAs) and long-acting muscarinic antagonists (LAMAs), and AERO-111, a triple combination product featuring an inhaled corticosteroid (ICS). These therapies aim to enhance efficacy and improve compliance among COPD patients in the US, where over 16 million individuals are affected by this disease.AeroRx Therapeutics has structured its business model around the development and commercialization of its nebulized therapies, focusing on partnerships within the healthcare sector. The company intends to generate revenue through direct sales to healthcare providers and institutions, alongside agreements with pharmaceutical distributors and wholesalers.In October 2025, AeroRx Therapeutics, Inc. The company is focused on launching new products and expanding into new markets, particularly targeting additional geographical regions where COPD prevalence is high.
Who invested in AeroRx Therapeu&cs
3 investors across 1 round
See all investors in AeroRx Therapeu&cs
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 25, 2025
Amount
$10M
Investors
Questions about AeroRx Therapeu&cs
Who invested in AeroRx Therapeu&cs?
AeroRx Therapeu&cs has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AeroRx Therapeu&cs raised?
AeroRx Therapeu&cs has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did AeroRx Therapeu&cs last raise money?
AeroRx Therapeu&cs's most recent round on record is a Series A, in Sep 2025.
What does AeroRx Therapeu&cs do?
AeroRx Therapeu&cs is a biotechnology company.
Where is AeroRx Therapeu&cs headquartered?
AeroRx Therapeu&cs is headquartered in La Jolla, US.
Which VCs invest in companies like AeroRx Therapeu&cs?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at AeroRx Therapeu&cs's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like AeroRx Therapeu&cs? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.